# Phyto Partners

Phyto Partners is a Private Equity based in Boca Raton, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Boca Raton, United States
- **Region:** North America
- **Address:** 2080 NW Boca Raton Blvd Suite #2, Boca Raton, FL 33431, United States
- **Founded:** 2015
- **Assets under management:** Undisclosed
- **Website:** phytopartners.com
- **LinkedIn:** https://www.linkedin.com/company/phyto-partners

## Regulatory record

- **Reports private funds:** No

## About

Mind Wellness Venture Capital Fund | Phyto Partners is a venture capital fund that invests in businesses operating in and around the Brain Health Mega Trend. The fund offers accredited investors a professionally managed vehicle to get involved in this rapidly growing market.

## Sectors

- Cannabis
- Healthcare Services
- Pharmaceuticals & Biotech

## People

- Larry Schnurmacher — Contact for all inquiries

## Questions

### How is Phyto Partners' psychedelic fund distinct from its cannabis fund?

Phyto Psyche applies the same venture framework — early-stage entry into a stigmatized, soon-to-be-regulated sector — to neurowellness and brain health. The parent firm sees this as structurally analogous to its 2015 cannabis entry, targeting companies before institutional capital arrives. Both funds focus on ancillary and service-layer businesses rather than direct cultivation or drug development.

### Does Phyto Partners invest in plant-touching cannabis businesses?

Phyto's stated preference is for high-margin products and services sold to licensed operators, not the operators themselves. Its cannabis portfolio includes ancillary picks like Marijuana Doctor and Agrify. This approach reduces direct federal regulatory exposure while capturing industry growth.

### How does Phyto Partners source deal flow in nascent regulated markets?

The firm credits its early cannabis success to connecting with the right people and providing venture capital to early industry operators, a phrase lifted from its website. It is publicly extending that network-based sourcing model into psychedelics. No proprietary sourcing channel is described beyond founder relationships and industry participant connectivity.

## Related profiles

- [Phystech Leadership Fund](https://altss.com/profile/phystech-leadership-fund)
- [PIA Investment Partners](https://altss.com/profile/pia-investment-partners)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/phyto-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology